Cardiovascular risk reduction with empagliflozin: exploring the evidence from EMPA-REG OUTCOME®.
27 August 2017 (13:00 - 13:15)
Organised by:
About the speaker
University of Lorraine, Vandoeuvre-Les-Nancy (France)
6 More presentations in this session
Professor N. Marx (Aachen, DE)
Professor D. McGuire (Dallas, US)
Doctor J. Udell (Toronto, CA)
Professor N. Marx (Aachen, DE)
Professor D. McGuire (Dallas, US)
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Doctor J. Udell (Toronto, CA)
Access the full session
The Event
ESC Congress 2017
27 August 2017
13:00 CET
You may be interested in
Congress Session
Congress Presentation
27 August 2022
Congress Presentation
3 September 2019
